• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型甲状腺细针抽吸:过去、现在和未来。

The atypical thyroid fine-needle aspiration: past, present, and future.

机构信息

Institute of Pathology, Locarno, Switzerland.

出版信息

Cancer Cytopathol. 2012 Apr 25;120(2):73-86. doi: 10.1002/cncy.20178. Epub 2011 Jul 12.

DOI:10.1002/cncy.20178
PMID:21751429
Abstract

Thyroid fine-needle aspiration has developed into a key test in the evaluation of thyroid nodules. Although the interpretation of thyroid aspirates containing mild abnormalities is problematic, the introduction of the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category in The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has helped to delineate such cases in a systematic and clinically meaningful manner. Herein the authors review the cytomorphologic features associated with the AUS/FLUS interpretation and summarize the results of studies conducted since the implementation of TBSRTC.

摘要

甲状腺细针抽吸术已发展成为评估甲状腺结节的关键检测手段。虽然含有轻度异常的甲状腺抽吸物的解读存在问题,但在《甲状腺细胞病理学报告的 Bethesda 系统》(TBSRTC)中引入意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS)类别有助于以系统和具有临床意义的方式描绘此类病例。本文作者回顾了与 AUS/FLUS 解读相关的细胞形态学特征,并总结了自 TBSRTC 实施以来开展的研究结果。

相似文献

1
The atypical thyroid fine-needle aspiration: past, present, and future.非典型甲状腺细针抽吸:过去、现在和未来。
Cancer Cytopathol. 2012 Apr 25;120(2):73-86. doi: 10.1002/cncy.20178. Epub 2011 Jul 12.
2
The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.应用亚分类和 BRAF 突变结果对甲状腺细胞病理学报告的 Bethesda 系统中“意义不明确的非典型性/滤泡性病变意义不明确”类别进行恶性风险预测。
Cancer Cytopathol. 2014 May;122(5):368-76. doi: 10.1002/cncy.21396. Epub 2014 Mar 3.
3
The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.意义不明确的非典型性/滤泡性病变及重复细针穿刺活检的影响:贝塞斯达系统实施前后5年
Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.
4
Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.从甲状腺细胞病理学报告的 Bethesda 系统中删除“意义不明确的非典型/滤泡性病变”类别。
Am J Clin Pathol. 2011 Dec;136(6):896-902. doi: 10.1309/AJCPIX52MBOKTICP.
5
Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.在甲状腺细胞病理学报告的 Bethesda 系统中,对于诊断不明确或意义不明确的非典型性甲状腺结节,核心针活检比重复细针抽吸更有用。
Thyroid. 2012 May;22(5):468-75. doi: 10.1089/thy.2011.0185. Epub 2012 Feb 3.
6
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
7
The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.在甲状腺细针穿刺中使用贝塞斯达术语可降低非恶性结节的手术率:来自土耳其一家参考中心的报告。
Int J Surg Pathol. 2011 Dec;19(6):761-71. doi: 10.1177/1066896911415667. Epub 2011 Jul 26.
8
Cytomorphologic, Imaging, Molecular Findings, and Outcome in Thyroid Follicular Lesion of Undetermined Significance/Atypical Cell of Undetermined Significance (AUS/FLUS): A Mini-Review.意义未明的甲状腺滤泡性病变/意义未明的非典型细胞(AUS/FLUS)的细胞形态学、影像学、分子学发现及结果:一篇综述
Acta Cytol. 2019;63(1):1-9. doi: 10.1159/000493908. Epub 2018 Oct 31.
9
Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.甲状腺细胞病理学报告贝塞斯达系统分析及类似的甲状腺前体细胞病理学报告方案。
Adv Anat Pathol. 2012 Sep;19(5):313-9. doi: 10.1097/PAP.0b013e3182666398.
10
Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.贝塞斯达不确定分类中的恶性肿瘤风险和瘤形成风险:对印度一家机构的4532例甲状腺细针穿刺抽吸术的研究
Acta Cytol. 2017;61(2):103-110. doi: 10.1159/000470825. Epub 2017 Apr 14.

引用本文的文献

1
Unveiling the Malignancy Risk of Surgically Treated Bethesda III Thyroid Nodules: A 10-Year Retrospective Study Comparing Fine-Needle Aspiration Cytology (FNAC) and Histopathology.揭示手术治疗的贝塞斯达III类甲状腺结节的恶性风险:一项比较细针穿刺细胞学检查(FNAC)和组织病理学的10年回顾性研究
Cureus. 2024 Dec 17;16(12):e75855. doi: 10.7759/cureus.75855. eCollection 2024 Dec.
2
UTILITY OF THE 2023 BETHESDA SYSTEM AUS SUBCATEGORIZATION ON THYROID ASPIRATES.2023年贝塞斯达系统对甲状腺细针穿刺抽吸物亚分类的实用性
Acta Endocrinol (Buchar). 2024 Jan-Mar;20(1):1-4. doi: 10.4183/aeb.2024.1. Epub 2024 Oct 3.
3
Pediatric Thyroid Lesions: Synergistic Role of Clinical and Cytological Features in Diagnosis.
小儿甲状腺病变:临床及细胞学特征在诊断中的协同作用
Discoveries (Craiova). 2023 Mar 31;11(1):e164. doi: 10.15190/d.2023.3. eCollection 2023 Jan-Mar.
4
A Study of Thyroid Fine Needle Aspiration of Follicular Adenoma in the "Atypia of Undetermined Significance" Bethesda Category Using Digital Image Analysis.一项使用数字图像分析对甲状腺细针穿刺活检中贝塞斯达分类为“意义未明的不典型病变”的滤泡性腺瘤的研究
J Pathol Inform. 2022 Jan 20;13:100004. doi: 10.1016/j.jpi.2022.100004. eCollection 2022.
5
Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III.甲状腺结节 Bethesda 分类为 III 类患者的手术结果和恶性危险因素。
Front Endocrinol (Lausanne). 2021 Sep 14;12:686849. doi: 10.3389/fendo.2021.686849. eCollection 2021.
6
Malignancy Rates of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cases: A Tertiary Center Study.意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS)病例的恶性率:一项三级中心研究
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(1):77-82. doi: 10.4183/aeb.2021.77.
7
Is Subdivision of Atypia of Undetermined Significance AUS/Follicular Lesion of Undetermined Significance Cases According to Detailed Nuclear Features Vital for Assessing the Risk of Malignancy?根据对评估恶性风险至关重要的详细核特征,对意义未明的非典型性/AUS/意义未明的滤泡性病变病例进行细分是否有必要?
J Cytol. 2020 Oct-Dec;37(4):204-209. doi: 10.4103/JOC.JOC_5_20. Epub 2020 Nov 6.
8
The value of repeating fine-needle aspiration for thyroid nodules.甲状腺结节细针穿刺抽吸术的重复价值。
Ann Saudi Med. 2021 Jan-Feb;41(1):36-42. doi: 10.5144/0256-4947.2021.36. Epub 2021 Feb 4.
9
Can Repeat Biopsies Change the Prognoses of AUS/FLUS Nodule?重复活检能否改变意义不明确的非典型鳞状细胞/意义不明确的滤泡状病变结节的预后?
Eur Thyroid J. 2020 Feb;9(2):92-98. doi: 10.1159/000504705. Epub 2019 Dec 3.
10
Distribution and malignancy risk of six categories of the pathology reporting system for thyroid core-needle biopsy in 1,216 consecutive thyroid nodules.1216例连续甲状腺结节的甲状腺粗针穿刺活检病理报告系统六类的分布及恶性风险
Ultrasonography. 2020 Apr;39(2):159-165. doi: 10.14366/usg.19056. Epub 2020 Jan 16.